DNA Methylation in the Pathogenesis of Autoimmunity

Gene Discovery for Disease Models

Volumn , Issue , 2012, Pages 31-58

  Xu, Xueqing ^a   Yang, Ping ^b   Shu, Zhang ^b   Bai, Yun ^a   Wang, Cong Yi ^b,c  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^c MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

DNA methylation implication in autoimmune diseases initiating heritable patterns of gene expression; DNA methylation, in autoimmunity pathogenesis type of post synthesis modification after every cycle of DNA replication; DNA methylome changes, and interactions between cis acting elements and protein factors, role in gene regulation

Indexed keywords

EID: 84886226456     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470933947.ch3     Document Type: Chapter

References (168)

1. Aggarwal BB, Shishodia S. (2006). Molecular targets of dietary agents for prevention and therapy of cancer. Biochem Pharmacol 71: 1397-421.
2. Alonzi T, Fattori E, Lazzaro D, Costa P, Probert L, Kollias G, De Benedetti F, Poli V, Ciliberto G. (1998). Interleukin 6 is required for the development of collagen-induced arthritis. J Exp Med 187: 461-68.
3. Amaravadi L, Klemsz MJ. (1999). DNA methylation and chromatin structure regulate PU.1 expression. DNA Cell Biol 18: 875-84.
4. Amir RE, Van DV, Wan M, Tran CQ, Francke U, Zoghbi HY. (1999). Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat Genet 23: 185-88.
5. Andersen AA, Panning B. (2003). Epigenetic gene regulation by noncoding RNAs. Curr Opin Cell Biol 15: 281-89.
6. Ariel M. (2001). A PCR-based method for studying DNA methylation. Methods Mol Biol 181: 205-16.
7. Atkinson MA. (2005). ADA Outstanding Scientific Achievement Lecture 2004. Thirty years of investigating the autoimmune basis for type 1 diabetes: why can't we prevent or reverse this disease? Diabetes 54: 1253-63.
8. Ballestar E, Esteller M, Richardson BC. (2006). The epigenetic face of systemic lupus erythematosus. J Immunol 176: 7143-47.
9. Ballestar E, Pile LA, Wassarman DA, Wolffe AP, Wade PA. (2001). A Drosophila MBD family member is a transcriptional corepressor associated with specific genes. Eur J Biochem 268: 5397-406.
10. Baron U, Floess S, Wieczorek G, Baumann K, Grutzkau A, Dong J, Thiel A, Boeld TJ, Hoffmann P, Edinger M, Turbachova I, Hamann A, Olek S, Huehn J. (2007). DNA demethylation in the human FOXP3 locus discriminates regulatory T cells from activated Foxp3(+) conventional T cells. Eur J Immunol 37: 2378-89.
11. Bestor TH, Ingram VM. (1983). Two DNA methyltransferases from murine erythroleukemia cells: purification, sequence specificity, and mode of interaction with DNA. Proc Natl Acad Sci U S A 80: 5559-63.
12. Bettini M, Vignali DA. (2009). Regulatory T cells and inhibitory cytokines in autoimmunity. Curr Opin Immunol 21: 612-18.
13. Bird AP, Wolffe AP. (1999). Methylation-induced repression - belts, braces, and chromatin. Cell 99: 451-54.
14. Bix M, Locksley RM. (1998). Independent and epigenetic regulation of the interleukin-4 alleles in CD4 + T cells. Science 281: 1352-54.
15. Bombail V, Moggs JG, Orphanides G. (2004). Perturbation of epigenetic status by toxicants. Toxicol Lett 149: 51-58.
16. Bowen H, Kelly A, Lee T, Lavender P. (2008). Control of cytokine gene transcription in Th1 and Th2 cells. Clin Exp Allergy 38: 1422-31.
17. Brenner C, Fuks F. (2006). DNA methyltransferases: facts, clues, mysteries. Curr Top Microbiol Immunol 301: 45-66.
18. Bruniquel D, Schwartz RH. (2003). Selective, stable demethylation of the interleukin-2 gene enhances transcription by an active process. Nat Immunol 4: 235-40.
19. Callinan PA, Feinberg AP. (2006). The emerging science of epigenomics. Hum Mol Genet 15 (Spec. no 1): R95-101.
20. Chappell C, Beard C, Altman J, Jaenisch R, Jacob J. (2006). DNA methylation by DNA methyltransferase 1 is critical for effector CD8 T cell expansion. J Immunol 176: 4562-72.
21. Cheng LC, Tavazoie M, Doetsch F. (2005). Stem cells: from epigenetics to microRNAs. Neuron 46: 363-67.
22. Dahlquist G. (1998). The aetiology of type 1 diabetes: an epidemiological perspective. Acta Paediatr Suppl 425: 5-10.
23. Danbara M, Kameyama K, Higashihara M, Takagaki Y. (2002). DNA methylation dominates transcriptional silencing of PAX5 in terminally differentiated B cell lines. Mol Immunol 38: 1161-66.
24. Deng C, Lu Q, Zhang Z, Rao T, Attwood J, Yung R, Richardson B. (2003). Hydralazine may induce autoimmunity by inhibiting extracellular signal-regulated kinase pathway signaling. Arthritis Rheum 48: 746-56.
25. Dennis C. (2003). Epigenetics and disease: altered states. Nature 421: 686-88.
26. Dolinoy DC, Weidman JR, Jirtle RL. (2006). Epigenetic gene regulation: linking early developmental environment to adult disease. Reprod Toxicol 23: 297-307.
27. Dubroff LM, Reid RJ Jr. (1980). Hydralazine-pyrimidine interactions may explain hydralazine-induced lupus erythematosus. Science 208: 404-06.
28. Eads CA, Danenberg KD, Kawakami K, Saltz LB, Blake C, Shibata D, Danenberg PV, Laird PW. (2000). MethyLight: a high-throughput assay to measure DNA methylation. Nucleic Acids Res 28: E32.
29. Egger G, Liang G, Aparicio A, Jones PA. (2004). Epigenetics in human disease and prospects for epigenetic therapy. Nature 429: 457-63.
30. Ehrlich M, Jackson K, Weemaes C. (2006). Immunodeficiency, centromeric region instability, facial anomalies syndrome (ICF). Orphanet J Rare Dis 1: 2.
31. Eisenstein EM, Williams CB. (2009). The T(reg)/Th17 cell balance: a new paradigm for autoimmunity. Pediatr Res 65: 26R-31R.
32. Eivazova ER, Aune TM. (2004). Dynamic alterations in the conformation of the IFN γ gene region during T helper cell differentiation. Proc Natl Acad Sci U S A 101: 251-56.
33. Esteller M. (2006). The necessity of a human epigenome project. Carcinogenesis 27: 1121-25.
34. Fatemi M, Hermann A, Gowher H, Jeltsch A. (2002). DNMT3a and Dnmt1 functionally cooperate during de novo methylation of DNA. Eur J Biochem 269: 4981-84.
35. Fatemi M, Wade PA. (2006). MBD family proteins: reading the epigenetic code. J Cell Sci 119: 3033-37.
36. Fields PE, Lee GR, Kim ST, Bartsevich VV, Flavell RA. (2004). Th2-specific chromatin remodeling and enhancer activity in the Th2 cytokine locus control region. Immunity 21: 865-76.
37. Filippi CM, von Herrath MG. (2008). Viral trigger for type 1 diabetes: pros and cons. Diabetes 57: 2863-71.
38. Fischle W, Wang Y, Allis CD. (2003). Histone and chromatin cross-talk. Curr Opin Cell Biol 15: 172-83.
39. Fitzpatrick DR, Shirley KM, Kelso A. (1999). Cutting edge: stable epigenetic inheritance of regional IFN-gamma promoter demethylation in CD44highCD8 + T lymphocytes. J Immunol 162: 5053-57.
40. Fitzpatrick DR, Wilson CB. (2003). Methylation and demethylation in the regulation of genes, cells, and responses in the immune system. Clin Immunol 109: 37-45.
41. Floess S, Freyer J, Siewert C, Baron U, Olek S, Polansky J, Schlawe K, Chang HD, Bopp T, Schmitt E, Klein-Hessling S, Serfling E, Hamann A, Huehn J. (2007). Epigenetic control of the Foxp3 locus in regulatory T cells. PLoS Biol 5: e38.
42. Fodor SP, Read JL, Pirrung MC, Stryer L, Lu AT, Solas D. (1991). Light-directed, spatially addressable parallel chemical synthesis. Science 251: 767-73.
43. Fraga MF, Ballestar E, Montoya G, Taysavang P, Wade PA, Esteller M. (2003). The affinity of different MBD proteins for a specific methylated locus depends on their intrinsic binding properties. Nucleic Acids Res 31: 1765-74.
44. Fraga MF, Ballestar E, Paz MF, Ropero S, Setien F, Ballestar ML, Heine-Suner D, Cigudosa JC, Urioste M, Benitez J, Boix-Chornet M, Sanchez-Aguilera A, Ling C, Carlsson E, Poulsen P, Vaag A, Stephan Z, Spector TD, Wu YZ, Plass C, Esteller M. (2005). Epigenetic differences arise during the lifetime of monozygotic twins. Proc Natl Acad Sci U S A 102: 10604-09.
45. Frigola J, Ribas M, Risques RA, Peinado MA. (2002). Methylome profiling of cancer cells by amplification of inter-methylated sites (AIMS). Nucleic Acids Res 30: e28.
46. Frommer M, McDonald LE, Millar DS, Collis CM, Watt F, Grigg GW, Molloy PL, Paul CL. (1992). A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands. Proc Natl Acad Sci U S A 89: 1827-31.
47. Fu S, Zhang N, Yopp AC, Chen D, Mao M, Chen D, Zhang H, Ding Y, Bromberg JS. (2004). TGF-beta induces Foxp3 + T-regulatory cells from CD4 + C. Am J Transplant 4: 1614-27.
48. Fuks F. (2005). DNA methylation and histone modifications: teaming up to silence genes. Curr Opin Genet Dev 15: 490-95.
49. Fulda S, Kufer MU, Meyer E, van Valen F, Dockhorn-Dworniczak B, Debatin KM. (2001). Sensitization for death receptor-or drug-induced apoptosis by re-expression of caspase-8 through demethylation or gene transfer. Oncogene 20: 5865-77.
50. Goll MG, Kirpekar F, Maggert KA, Yoder JA, Hsieh CL, Zhang X, Golic KG, Jacobsen SE, Bestor TH. (2006). Methylation of tRNAAsp by the DNA methyltransferase homolog DNMT2. Science 311: 395-98.
51. Gonzalgo ML, Liang G, Spruck CH III, Zingg JM, Rideout WM III, Jones PA. (1997). Identification and characterization of differentially methylated regions of genomic DNA by methylation-sensitive arbitrarily primed PCR. Cancer Res 57: 594-99.
52. Gopisetty G, Ramachandran K, Singal R. (2006). DNA methylation and apoptosis. Mol Immunol 43: 1729-40.
53. Goyal R, Reinhardt R, Jeltsch A. (2006). Accuracy of DNA methylation pattern preservation by the DNMT1 methyltransferase. Nucleic Acids Res 34: 1182-88.
54. Grogan JL, Mohrs M, Harmon B, Lacy DA, Sedat JW, Locksley RM. (2001). Early transcription and silencing of cytokine genes underlie polarization of T helper cell subsets. Immunity 14: 205-15.
55. Hansen RS, Wijmenga C, Luo P, Stanek AM, Canfield TK, Weemaes CM, Gartler SM. (1999). The DNMT3B DNA methyltransferase gene is mutated in the ICF immunodeficiency syndrome. Proc Natl Acad Sci U S A 96: 14412-17.
56. Hatton RD, Harrington LE, Luther RJ, Wakefield T, Janowski KM, Oliver JR, Lallone RL, Murphy KM, Weaver CT. (2006). A distal conserved sequence element controls Ifng gene expression by T cells and NK cells. Immunity 25: 717-29.
57. Hayashi H, Nagae G, Tsutsumi S, Kaneshiro K, Kozaki T, Kaneda A, Sugisaki H, Aburatani H. (2007). High-resolution mapping of DNA methylation in human genome using oligonucleotide tiling array. Hum Genet 120: 701-11.
58. Heller G, Zielinski CC, Zochbauer-Muller S. (2010). Lung cancer: from single-gene methylation to methylome profiling. Cancer Metastasis Rev 29 (1): 95-107.
59. Hendrich B, Abbott C, McQueen H, Chambers D, Cross S, Bird A. (1999). Genomic structure and chromosomal mapping of the murine and human MBD1, MBD2, MBD3, and MBD4 genes. Mamm Genome 10: 906-12.
60. Hendrich B, Bird A. (1998). Identification and characterization of a family of mammalian methyl-CpG binding proteins. Mol Cell Biol 18: 6538-47.
61. Hendrich B, Guy J, Ramsahoye B, Wilson VA, Bird A. (2001). Closely related proteins MBD2 and MBD3 play distinctive but interacting roles in mouse development. Genes Dev 15: 710-23.
62. Hendrich B, Tweedie S. (2003). The methyl-CpG binding domain and the evolving role of DNA methylation in animals. Trends Genet 19: 269-77.
63. Henikoff S, Furuyama T, Ahmad K. (2004). Histone variants, nucleosome assembly and epigenetic inheritance. Trends Genet 20: 320-26.
64. Herman JG, Graff JR, Myohanen S, Nelkin BD, Baylin SB. (1996). Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci U S A 93: 9821-26.
65. Hodge DR, Xiao W, Clausen PA, Heidecker G, Szyf M, Farrar WL. (2001). Interleukin-6 regulation of the human DNA methyltransferase (HDNMT) gene in human erythroleukemia cells. J Biol Chem 276: 39508-11.
66. Hofstetter H, Gold R, Hartung HP. (2009). Th17 cells in MS and experimental autoimmune encephalomyelitis. Int MS J 16: 12-18.
67. Holliday R. (2006). Dual inheritance. Curr Top Microbiol Immunol 301: 243-56.
68. Hutchins AS, Artis D, Hendrich BD, Bird AP, Scott P, Reiner SL. (2005). Cutting edge: a critical role for gene silencing in preventing excessive type 1 immunity. J Immunol 175: 5606-10.
69. Hutchins AS, Mullen AC, Lee HW, Sykes KJ, High FA, Hendrich BD, Bird AP, Reiner SL. (2002). Gene silencing quantitatively controls the function of a developmental trans-activator. Mol Cell 10: 81-91.
70. Ivanov II, McKenzie BS, Zhou L, Tadokoro CE, Lepelley A, Lafaille JJ, Cua DJ, Littman DR. (2006). The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17 + T helper cells. Cell 126: 1121-33.
71. Janson PC, Winerdal ME, Marits P, Thorn M, Ohlsson R, Winqvist O. (2008). Foxp3 promoter demethylation reveals the committed Treg population in humans. PLoS One 3: e1612.
72. Jeltsch A, Walter J, Reinhardt R, Platzer M. (2006). German human methylome project started. Cancer Res 66: 73-78.
73. Jones B, Chen J. (2006). Inhibition of IFN-gamma transcription by site-specific methylation during T helper cell development. EMBO J 25: 2443-52.
74. Jones PA, Martienssen R. (2005). A blueprint for a Human Epigenome Project: the AACR Human Epigenome Workshop. Cancer Res 65: 11241-46.
75. Junien C, Gallou-Kabani C, Vige A, Gross MS. (2005). [Nutritionnal epigenomics: consequences of unbalanced diets on epigenetics processes of programming during lifespan and between generations]. Ann Endocrinol (Paris) 66: 2S19-28.
76. Kaplan MJ, Lu Q, Wu A, Attwood J, Richardson B. (2004). Demethylation of promoter regulatory elements contributes to perforin overexpression in CD4 + lupus T cells. J Immunol 172: 3652-61.
77. Karouzakis E, Gay RE, Michel BA, Gay S, Neidhart M. (2009). DNA hypomethylation in rheumatoid arthritis synovial fibroblasts. Arthritis Rheum 60: 3613-22.
78. Kim HP, Leonard WJ. (2007). CREB/ATF-dependent T cell receptor-induced FoxP3 gene expression: a role for DNA methylation. J Exp Med 204: 1543-51.
79. Knip M, Veijola R, Virtanen SM, Hyoty H, Vaarala O, Akerblom HK. (2005). Environmental triggers and determinants of type 1 diabetes. Diabetes 54 (Suppl 2): S125-36.
80. Komatsu N, Mariotti-Ferrandiz ME, Wang Y, Malissen B, Waldmann H, Hori S. (2009). Heterogeneity of natural Foxp3 + T cells: a committed regulatory T-cell lineage and an uncommitted minor population retaining plasticity. Proc Natl Acad Sci U S A 106: 1903-08.
81. Korb A, Pavenstadt H, Pap T. (2009). Cell death in rheumatoid arthritis. Apoptosis 14: 447-54.
82. Koturbash I, Baker M, Loree J, Kutanzi K, Hudson D, Pogribny I, Sedelnikova O, Bonner W, Kovalchuk O. (2006a). Epigenetic dysregulation underlies radiation-induced transgenerational genome instability in vivo. Int J Radiat Oncol Biol Phys 66: 327-30.
83. Koturbash I, Rugo RE, Hendricks CA, Loree J, Thibault B, Kutanzi K, Pogribny I, Yanch JC, Engelward BP, Kovalchuk O. (2006b). Irradiation induces DNA damage and modulates epigenetic effectors in distant bystander tissue in vivo. Oncogene 25: 4267-75.
84. Kouskouti A, Talianidis I. (2005). Histone modifications defining active genes persist after transcriptional and mitotic inactivation. EMBO J 24: 347-57.
85. Lal G, Zhang N, van der Touw W, Ding Y, Ju W, Bottinger EP, Reid SP, Levy DE, Bromberg JS. (2009). Epigenetic regulation of Foxp3 expression in regulatory T cells by DNA methylation. J Immunol 182: 259-73.
86. Lee BH, Yegnasubramanian S, Lin X, Nelson WG. (2005). Procainamide is a specific inhibitor of DNA methyltransferase 1. J Biol Chem 280: 40749-56.
87. Lee DU, Agarwal S, Rao A. (2002). Th2 lineage commitment and efficient IL-4 production involves extended demethylation of the IL-4 gene. Immunity 16: 649-60.
88. Leonhardt H, Page AW, Weier HU, Bestor TH. (1992). A targeting sequence directs DNA methyltransferase to sites of DNA replication in mammalian nuclei. Cell 71: 865-73.
89. Li HP, Leu YW, Chang YS. (2005a). Epigenetic changes in virus-associated human cancers. Cell Res 15: 262-71.
90. Li JZ, Steinman CR. (1989). Plasma DNA in systemic lupus erythematosus. Characterization of cloned base sequences. Arthritis Rheum 32: 726-33.
91. Li M, Guo D, Isales CM, Eizirik DL, Atkinson M, She JX, Wang CY. (2005b). Sumo wrestling with type 1 diabetes. J Mol Med 83: 504-13.
92. Liu L, Wylie RC, Andrews LG, Tollefsbol TO. (2003). Aging, cancer and nutrition: the DNA methylation connection. Mech Ageing Dev 124: 989-98.
93. Luo X, Zhang Q, Liu V, Xia Z, Pothoven KL, Lee C. (2008). Cutting edge: TGF-beta-induced expression of Foxp3 in T cells is mediated through inactivation of ERK. J Immunol 180: 2757-61.
94. Maekita T, Nakazawa K, Mihara M, Nakajima T, Yanaoka K, Iguchi M, Arii K, Kaneda A, Tsukamoto T, Tatematsu M, Tamura G, Saito D, Sugimura T, Ichinose M, Ushijima T. (2006). High levels of aberrant DNA methylation in Helicobacter pylori-infected gastric mucosae and its possible association with gastric cancer risk. Clin Cancer Res 12: 989-95.
95. Maier H, Colbert J, Fitzsimmons D, Clark DR, Hagman J. (2003). Activation of the early B-cell-specific MB-1 (IG-alpha) gene by Pax-5 is dependent on an unmethylated ETS binding site. Mol Cell Biol 23: 1946-60.
96. Makar KW, Perez-Melgosa M, Shnyreva M, Weaver WM, Fitzpatrick DR, Wilson CB. (2003). Active recruitment of DNA methyltransferases regulates interleukin 4 in thymocytes and T cells. Nat Immunol 4: 1183-90.
97. Makar KW, Wilson CB. (2004). DNA methylation is a nonredundant repressor of the Th2 effector program. J Immunol 173: 4402-06.
98. Mattick JS. (2001). Non-coding RNAs: the architects of eukaryotic complexity. EMBO Rep 2: 986-91.
99. Mazari L, Ouarzane M, Zouali M. (2007). Subversion of B lymphocyte tolerance by hydralazine, a potential mechanism for drug-induced lupus. Proc Natl Acad Sci U S A 104: 6317-22.
100. Meaney MJ, Szyf M. (2005). Environmental programming of stress responses through DNA methylation: life at the interface between a dynamic environment and a fixed genome. Dialogues Clin Neurosci 7: 103-23.
101. Meehan RR, Lewis JD, Bird AP. (1992). Characterization of MeCP2, a vertebrate DNA binding protein with affinity for methylated DNA. Nucleic Acids Res 20: 5085-92.
102. Metcalfe KA, Hitman GA, Rowe RE, Hawa M, Huang X, Stewart T, Leslie RD. (2001). Concordance for type 1 diabetes in identical twins is affected by insulin genotype. Diabetes Care 24: 838-42.
103. Millar CB, Guy J, Sansom OJ, Selfridge J, MacDougall E, Hendrich B, Keightley PD, Bishop SM, Clarke AR, Bird A. (2002). Enhanced CpG mutability and tumorigenesis in MBD4-deficient mice. Science 297: 403-05.
104. Miyara M, Yoshioka Y, Kitoh A, Shima T, Wing K, Niwa A, Parizot C, Taflin C, Heike T, Valeyre D, Mathian A, Nakahata T, Yamaguchi T, Nomura T, Ono M, Amoura Z, Gorochov G, Sakaguchi S. (2009). Functional delineation and differentiation dynamics of human CD4 + T cells expressing the FoxP3 transcription factor. Immunity 30: 899-911.
105. Moon C, Kim SH, Park KS, Choi BK, Lee HS, Park JB, Choi GS, Kwan JH, Joh JW, Kim SJ. (2009). Use of epigenetic modification to induce Foxp3 expression in naive T cells. Transplant Proc 41: 1848-54.
106. Morgan HD, Sutherland HG, Martin DI, Whitelaw E. (1999). Epigenetic inheritance at the agouti locus in the mouse. Nat Genet 23: 314-18.
107. Natoli G, Saccani S, Bosisio D, Marazzi I. (2005). Interactions of NF-kappaB with chromatin: the art of being at the right place at the right time. Nat Immunol 6: 439-45.
108. Neidhart M, Rethage J, Kuchen S, Kunzler P, Crowl RM, Billingham ME, Gay RE, Gay S. (2000). Retrotransposable L1 elements expressed in rheumatoid arthritis synovial tissue: association with genomic DNA hypomethylation and influence on gene expression. Arthritis Rheum 43: 2634-47.
109. Nile CJ, Read RC, Akil M, Duff GW, Wilson AG. (2008). Methylation status of a single CpG site in the IL6 promoter is related to IL6 messenger RNA levels and rheumatoid arthritis. Arthritis Rheum 58: 2686-93.
110. Nishimoto N, Yoshizaki K, Miyasaka N, Yamamoto K, Kawai S, Takeuchi T, Hashimoto J, Azuma J, Kishimoto T. (2004). Treatment of rheumatoid arthritis with humanized anti-interleukin-6 receptor antibody: a multicenter, double-blind, placebo-controlled trial. Arthritis Rheum 50: 1761-69.
111. Nuwaysir EF, Huang W, Albert TJ, Singh J, Nuwaysir K, Pitas A, Richmond T, Gorski T, Berg JP, Ballin J, McCormick M, Norton J, Pollock T, Sumwalt T, Butcher L, Porter D, Molla M, Hall C, Blattner F, Sussman MR, Wallace RL, Cerrina F, Green RD. (2002). Gene expression analysis using oligonucleotide arrays produced by maskless photolithography. Genome Res 12: 1749-55.
112. Ohki I, Shimotake N, Fujita N, Jee J, Ikegami T, Nakao M, Shirakawa M. (2001). Solution structure of the methyl-CpG binding domain of human MBD1 in complex with methylated DNA. Cell 105: 487-97.
113. Pasare C, Medzhitov R. (2003). Toll pathway-dependent blockade of CD4 + CD25 + T cell-mediated suppression by dendritic cells. Science 299: 1033-36.
114. Pease AC, Solas D, Sullivan EJ, Cronin MT, Holmes CP, Fodor SP. (1994). Light-generated oligonucleotide arrays for rapid DNA sequence analysis. Proc Natl Acad Sci U S A 91: 5022-26.
115. Quddus J, Johnson KJ, Gavalchin J, Amento EP, Chrisp CE, Yung RL, Richardson BC. (1993). Treating activated CD4 + T cells with either of two distinct DNA methyltransferase inhibitors, 5-azacytidine or procainamide, is sufficient to cause a lupus-like disease in syngeneic mice. J Clin Invest 92: 38-53.
116. Rakyan VK, Chong S, Champ ME, Cuthbert PC, Morgan HD, Luu KV, Whitelaw E. (2003). Transgenerational inheritance of epigenetic states at the murine Axin(Fu) allele occurs after maternal and paternal transmission. Proc Natl Acad Sci U S A 100: 2538-43.
117. Rauscher FJ III. (2005). It is time for a Human Epigenome Project. Cancer Res 65: 11229.
118. Reiner SL. (2005). Epigenetic control in the immune response. Hum Mol Genet 14 (Special issue 1): R41-46.
119. Renaudineau Y, Garaud S, Le, DC, Onso-ramirez R, Daridon C, Youinou P. (2009). Autoreactive B cells and epigenetics. Clin Rev Allergy Immunol 39: 85-94.
120. Richardson B. (1986). Effect of an inhibitor of DNA methylation on T cells. II. 5-Azacytidine induces self-reactivity in antigen-specific T4 + cells. Hum Immunol 17: 456-70.
121. Richardson B. (2003). DNA methylation and autoimmune disease. Clin Immunol 109: 72-79.
122. Richardson B, Scheinbart L, Strahler J, Gross L, Hanash S, Johnson M. (1990). Evidence for impaired T cell DNA methylation in systemic lupus erythematosus and rheumatoid arthritis. Arthritis Rheum 33: 1665-73.
123. Richardson BC, Strahler JR, Pivirotto TS, Quddus J, Bayliss GE, Gross LA, O'Rourke KS, Powers D, Hanash SM, Johnson MA. (1992). Phenotypic and functional similarities between 5-azacytidine-treated T cells and a T cell subset in patients with active systemic lupus erythematosus. Arthritis Rheum 35: 647-62.
124. Sadri R, Hornsby PJ. (1996). Rapid analysis of DNA methylation using new restriction enzyme sites created by bisulfite modification. Nucleic Acids Res 24: 5058-59.
125. Samanta A, Li B, Song X, Bembas K, Zhang G, Katsumata M, Saouaf SJ, Wang Q, Hancock WW, Shen Y, Greene MI. (2008). TGF-beta and IL-6 signals modulate chromatin binding and promoter occupancy by acetylated FOXP3. Proc Natl Acad Sci U S A 105: 14023-27.
126. Sano H, Imokawa M, Steinberg AD, Morimoto C. (1983). Accumulation of guanine-cytosine-enriched low M.W. DNA fragments in lymphocytes of patients with systemic lupus erythematosus. J Immunol 130: 187-90.
127. Sansom OJ, Berger J, Bishop SM, Hendrich B, Bird A, Clarke AR. (2003). Deficiency of MBD2 suppresses intestinal tumorigenesis. Nat Genet 34: 145-47.
128. Santangelo S, Cousins DJ, Winkelmann NE, Staynov DZ. (2002). DNA methylation changes at human Th2 cytokine genes coincide with DNase I hypersensitive site formation during CD4(+) T Cell differentiation. J Immunol 169: 1893-903.
129. Schwab J, Illges H. (2001). Silencing of CD21 expression in synovial lymphocytes is independent of methylation of the CD21 promoter CpG island. Rheumatol Int 20: 133-37.
130. Sekigawa I, Kawasaki M, Ogasawara H, Kaneda K, Kaneko H, Takasaki Y, Ogawa H. (2006). DNA methylation: its contribution to systemic lupus erythematosus. Clin Exp Med 6: 99-106.
131. Sekigawa I, Okada M, Ogasawara H, Kaneko H, Hishikawa T, Hashimoto H. (2003). DNA methylation in systemic lupus erythematosus. Lupus 12: 79-85.
132. Shirohzu H, Kubota T, Kumazawa A, Sado T, Chijiwa T, Inagaki K, Suetake I, Tajima S, Wakui K, Miki Y, Hayashi M, Fukushima Y, Sasaki H. (2002). Three novel DNMT3B mutations in Japanese patients with ICF syndrome. Am J Med Genet 112: 31-37.
133. Sutherland JE, Costa M. (2003). Epigenetics and the environment. Ann N Y Acad Sci 983: 151-60.
134. Takami N, Osawa K, Miura Y, Komai K, Taniguchi M, Shiraishi M, Sato K, Iguchi T, Shiozawa K, Hashiramoto A, Shiozawa S. (2006). Hypermethylated promoter region of DR3, the death receptor 3 gene, in rheumatoid arthritis synovial cells. Arthritis Rheum 54: 779-87.
135. Tao Q, Robertson KD. (2003). Stealth technology: how Epstein-Barr virus utilizes DNA methylation to cloak itself from immune detection. Clin Immunol 109: 53-63.
136. Teferedegne B, Green MR, Guo Z, Boss JM. (2006). Mechanism of action of a distal NF-kappaB-dependent enhancer. Mol Cell Biol 26: 5759-70.
137. Teitell M, Richardson B. (2003). DNA methylation in the immune system. Clin Immunol 109: 2-5.
138. Thomas TJ, Seibold JR, Adams LE, Hess EV. (1993). Hydralazine induces Z-DNA conformation in a polynucleotide and elicits anti(Z-DNA) antibodies in treated patients. Biochem J 294 (Pt 2): 419-25.
139. Tollefsbol TO. (2004). Methods of epigenetic analysis. Methods Mol Biol 287: 1-8.
140. Toyota M, Ho C, Ahuja N, Jair KW, Li Q, Ohe-Toyota M, Baylin SB, Issa JP. (1999). Identification of differentially methylated sequences in colorectal cancer by methylated CpG island amplification. Cancer Res 59: 2307-12.
141. Trouche D, Khochbin S, Dimitrov S. (2003). Chromatin and epigenetics: dynamic organization meets regulated function. Mol Cell 12: 281-86.
142. Ushijima T, Nakajima T, Maekita T. (2006). DNA methylation as a marker for the past and future. J Gastroenterol 41: 401-07.
143. van der Werf N, Kroese FG, Rozing J, Hillebrands JL. (2007). Viral infections as potential triggers of type 1 diabetes. Diabetes Metab Res Rev 23: 169-83.
144. Van Helden PD. (1985). Potential Z-DNA-forming elements in serum DNA from human systemic lupus erythematosus. J Immunol 134: 177-79.
145. Vanden Berghe W, Ndlovu MN, Hoya-Arias R, Dijsselbloem N, Gerlo S, Haegeman G. (2006). Keeping up NF-kappaB appearances: epigenetic control of immunity or inflammation-triggered epigenetics. Biochem Pharmacol 72: 1114-31.
146. Wade PA. (2001). Methyl CpG-binding proteins and transcriptional repression. Bioessays 23: 1131-37.
147. Walter K, Bonifer C, Tagoh H. (2008). Stem cell-specific epigenetic priming and B cell-specific transcriptional activation at the mouse CD19 locus. Blood 112: 1673-82.
148. Wang CY, Han J, She JX. (2008). Genetic factors for human type 1 diabetes. In Current Topics in Human Genetics (Studies in Complex Diseases). Vol. 24. Ed. World Scientific Publishing Co. Pte. Ltd., Hackensack, NJ 07601, pp. 693-727.
149. Wang CY, Podolsky R, She JX. (2006). Genetic and functional evidence supporting SUMO4 as a type 1 diabetes susceptibility gene. Ann N Y Acad Sci 1079: 257-67.
150. Wang CY, She JX. (2008). SUMO4 and its role in type 1 diabetes pathogenesis. Diabetes Metab Res Rev 24: 93-102.
151. Wardle EN. (2009). Systemic lupus erythematosus conundrums. Saudi J Kidney Dis Transpl 20: 731-36.
152. Waterland RA, Jirtle RL. (2004). Early nutrition, epigenetic changes at transposons and imprinted genes, and enhanced susceptibility to adult chronic diseases. Nutrition 20: 63-68.
153. Welsh J, McClelland M. (1990). Fingerprinting genomes using PCR with arbitrary primers. Nucleic Acids Res 18: 7213-18.
154. Wen ZK, Xu W, Xu L, Cao QH, Wang Y, Chu YW, Xiong SD. (2007). DNA hypomethylation is crucial for apoptotic DNA to induce systemic lupus erythematosus-like autoimmune disease in SLE-non-susceptible mice. Rheumatology (Oxford) 46: 1796-803.
155. Williams KT, Garrow TA, Schalinske KL. (2008). Type I diabetes leads to tissue-specific DNA hypomethylation in male rats. J Nutr 138: 2064-69.
156. Wilson CB, Rowell E, Sekimata M. (2009). Epigenetic control of T-helper-cell differentiation. Nat Rev Immunol 9: 91-105.
157. Wilson IM, Davies JJ, Weber M, Brown CJ, Alvarez CE, MacAulay C, Schubeler D, Lam WL. (2006). Epigenomics: mapping the methylome. Cell Cycle 5: 155-58.
158. Wing K, Sakaguchi S. (2010). Regulatory T cells exert checks and balances on self tolerance and autoimmunity. Nat Immunol 11: 7-13.
159. Wu J, Smith LT, Plass C, Huang TH. (2006). ChIP-chip comes of age for genome-wide functional analysis. Cancer Res 66: 6899-902.
160. Yuan X, Paez-Cortez J, Schmitt-Knosalla I, D'Addio F, Mfarrej B, Donnarumma M, Habicht A, Clarkson MR, Iacomini J, Glimcher LH, Sayegh MH, Ansari MJ. (2008). A novel role of CD4 Th17 cells in mediating cardiac allograft rejection and vasculopathy. J Exp Med 205: 3133-44.
161. Yung R, Powers D, Johnson K, Amento E, Carr D, Laing T, Yang J, Chang S, Hemati N, Richardson B. (1996). Mechanisms of drug-induced lupus. II. T cells overexpressing lymphocyte function-associated antigen 1 become autoreactive and cause a lupuslike disease in syngeneic mice. J Clin Invest 97: 2866-71.
162. Yung R, Ray D, Eisenbraun JK, Deng C, Attwood J, Eisenbraun MD, Johnson K, Miller RA, Hanash S, Richardson B. (2001). Unexpected effects of a heterozygous dnmt1 null mutation on age-dependent DNA hypomethylation and autoimmunity. J Gerontol A Biol Sci Med Sci 56: B268-76.
163. Yung RL, Quddus J, Chrisp CE, Johnson KJ, Richardson BC. (1995). Mechanism of drug-induced lupus. I. Cloned Th2 cells modified with DNA methylation inhibitors in vitro cause autoimmunity in vivo. J Immunol 154: 3025-35.
164. Yung RL, Richardson BC. (1994). Role of T cell DNA methylation in lupus syndromes. Lupus 3: 487-91.
165. Zhao X, Ueba T, Christie BR, Barkho B, McConnell MJ, Nakashima K, Lein ES, Eadie BD, Willhoite AR, Muotri AR, Summers RG, Chun J, Lee KF, Gage FH. (2003). Mice lacking methyl-CpG binding protein 1 have deficits in adult neurogenesis and hippocampal function. Proc Natl Acad Sci U S A 100: 6777-82.
166. Zhou L, Chong MM, Littman DR. (2009a). Plasticity of CD4 + T cell lineage differentiation. Immunity 30: 646-55.
167. Zhou X, Bailey-Bucktrout S, Jeker LT, Bluestone JA. (2009b). Plasticity of CD4(+) FoxP3(+) T cells. Curr Opin Immunol 21: 281-85.
168. Zorn E, Nelson EA, Mohseni M, Porcheray F, Kim H, Litsa D, Bellucci R, Raderschall E, Canning C, Soiffer RJ, Frank DA, Ritz J. (2006). IL-2 regulates Foxp3 expression in human CD4 + CD25 + regulatory T cells through a STAT-dependent mechanism and induces the expansion of these cells in vivo. Blood 108: 1571-79.